Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Mar. 31, 2023
CURRENT ASSETS
Cash	$ 786,060	$ 570,460
Accounts receivable, net	1,468,655	1,224,137
Inventory [Note 3]	1,879,402	2,337,006
Deposits and other receivables	336,456	588,599
Total current assets	4,470,573	4,720,202
Deposits and other receivables [Note 12]	85,000	85,000
Long-term accounts receivable	149,907	96,344
Property and equipment [Note 13]	15,552	21,506
Operating right of use assets [Note 12]	1,221,593	1,587,492
TOTAL ASSETS	5,942,625	6,510,544
CURRENT LIABILITIES
Accounts payable and accrued liabilities [Note 4]	9,613,118	5,042,476
Convertible promissory notes and short term loans [Note 5]	9,236,471	4,774,468
Term loan, current	2,400,000
Derivative liabilities [Note 8]	991,866	1,008,216
Operating lease obligations, current [Note 10]	457,371	335,608
Total current liabilities	22,698,826	11,160,768
Federally guaranteed loans [Note 7]	870,800	870,800
Term loan [Note 6]	9,985,033	12,178,809
Derivative liabilities [Note 8]	1,435,668	759,065
Operating lease obligations	929,115	1,386,487
TOTAL LIABILITIES	35,919,442	26,355,929
STOCKHOLDERS’ DEFICIENCY
Common stock, $0.001 par value, 125,000,000 authorized as at March 31, 2024 and March 31, 2023, respectively. Issued and outstanding common shares: 9,353,768 and 8,508,052 as at March 31, 2024 and March 31, 2023, respectively, and exchangeable shares of 160,672 and 244,458 outstanding as at March 31, 2024 and March 31, 2023, respectively [Note 9]	9,515	8,753
Shares to be issued (344,276 and 3,955 shares of common stock as at March 31, 2024 and March 31, 2023, respectively) [Note 9]	269,065	24,999
Additional paid-in-capital	95,723,083	92,844,478
Accumulated other comprehensive gain (loss)	32,378	(152,797)
Accumulated deficit	(127,499,785)	(112,570,825)
Total stockholders’ deficiency	(31,465,737)	(19,845,385)
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIENCY	5,942,625	6,510,544
Serie B Convertible Redeemable Preferred Stock [Member]
MEZZANINE EQUITY
Series B Convertible Redeemable preferred stock, $0.001 par value, 600 and no shares authorized as of March 31, 2024 and March 31, 2023, respectively, 265 and no shares issued and outstanding as of March 31, 2024 and March 31, 2023, respectively [Note 9]	1,488,920
Preferred Stock [Member]
STOCKHOLDERS’ DEFICIENCY
Preferred stock, value	1	1
Series A Preferred Stock [Member]
STOCKHOLDERS’ DEFICIENCY
Preferred stock, value	$ 6	$ 6